10.01.2008 18:30:00

Industry-Leading Piper Jaffray Health Care Investment Banking Team Adds Michael Brinkman

MINNEAPOLIS, Jan. 10 /PRNewswire-FirstCall/ -- Piper Jaffray today announced Michael Brinkman has joined the investment banking team to expand its health care practice on the West Coast. He will be based in the Palo Alto office and joins a team that has helped Piper Jaffray become one of the most active underwriters for growth companies in the health care industry globally*.

Brinkman joins Piper Jaffray as a managing director in the health care group, focusing on biopharmaceutical companies. He has extensive experience in public and private financings, and in advising companies on mergers and acquisitions. Previously, he was a managing director and head of biotechnology investment banking at CIBC World Markets.

"Michael is an extremely talented banker who brings extensive experience as a lead advisor in the biopharmaceutical sector," said Jon Salveson, head of investment banking at Piper Jaffray. "For 25 years, we have been steady and committed to the business of health care. Adding an energized and seasoned professional like Michael to our leading health care platform is an extension of that long-term commitment of Piper Jaffray -- a commitment which our clients have come to expect."

Brinkman earned a bachelor's degree from the University of Witwatersrand in South Africa and completed his fellowship at the Faculty of Actuaries in Edinburgh, Scotland.

*Source: Dealogic and Piper Jaffray ECM; includes deals greater than $20 million in deal size

About Piper Jaffray

Piper Jaffray Companies is a leading, international middle-market investment bank and institutional securities firm, serving the needs of middle-market corporations, private equity groups, public entities, nonprofit clients and institutional investors. Founded in 1895, Piper Jaffray provides a comprehensive set of products and services, including equity and debt capital markets products; public finance services; mergers and acquisitions advisory services; high-yield and structured products; institutional equity and fixed-income sales and trading; and equity and high-yield research. With headquarters in Minneapolis, Piper Jaffray has 25 offices across the United States and international locations in London, Hong Kong, Shanghai and Beijing. Piper Jaffray & Co. is the firm's principal operating subsidiary. (http://www.piperjaffray.com/)

Since 1895. Member SIPC and FINRA.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Piper Jaffray Companiesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Piper Jaffray Companies 324,00 0,00% Piper Jaffray Companies

Indizes in diesem Artikel

S&P 600 SmallCap 935,46 -0,94%